PER 1.41% 7.0¢ percheron therapeutics limited

atl1103 development update, page-76

  1. 1,360 Posts.
    lightbulb Created with Sketch. 2158
    Rob you have clearly not read the announcement correctly as it says initial results early to mid 2013 and we know that the phs1 results came in earlier then expected so ANP seem to be on the ball wit time frames. Did you read it correctly or deliberately leave out the "early" in the early to mid 2013 in your post. Here it is for you from the announcement yesterday just in case you read it wrong and id point you in the right direction. Anything to help out a fellow speculator in this market. lol.
    ---------------------------------------
    "The Company is well advanced in its planning for the next trial of ATL1103 and expects to be in a
    position to commence the trial by or prior to mid 2012 with interim results potentially available in
    early to mid 2013."
    -------------------------------------------

    Anyway the rest of the update read very well with the due diligence part of the update the really juicy part. Its advanced to the next level and the inclusion of possible outcomes in terms of payments and milestones points to a deal getting closer. The patent application with a joint treatment with somavert is a real big one in my mind and points to pfizer being the possible partner. If you go back through my posts way back ago i posted that i believed pfizer may well be looking at a deal with ANP for ATL1103.

    Anyway as i said in my previous posts i have spoken to Mark Diamond on numerous occasions and i assure you that the board is doing its utmost best to get the best possible outcome for shareholders with this possible deal.

    Also a highly credentialed Scientific Advisory Group put together to oversee the clinical development of ATl1103 and we see that funding arrangements must be close as they stated that more news on the trial when funding finalised so they must be in the process now.

    Speculation or not the update said it all and gave hints as to possible outcomes and clearly stated the due diligence is progressing positively towards a potential development partnering and or licensing deal. Not guaranteed as yet but till its signed sealed and delivered yes speculation but least now we know its progressing. Like ive said in the past id rather be in then on the sidelines waiting for the trading halt and gap up on a deal. Everyone need to make their own investment decision on that call. Good luck.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.